Kin T. Chan

Pokfulam Road
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.

Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.

Journal: Theranostics

Published: June 16, 2020

MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1.

MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1.

Journal: Cancer science

Published: May 08, 2019

Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance.

Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance.

Journal: Theranostics

Published: October 02, 2018

Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.

Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: December 28, 2017

Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.

Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.

Journal: Cancer research and treatment

Published: July 25, 2017

Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.

Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: May 21, 2017

Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.

Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.

Journal: The Journal of pathology

Published: March 29, 2017

Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients.

Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients.

Journal: Oncology letters

Published: November 18, 2016

Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.

Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.

Journal: Nature communications

Published: March 30, 2016

Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.

Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.

Journal: Expert opinion on therapeutic targets

Published: November 17, 2015

Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts.

Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts.

Journal: Cancer chemotherapy and pharmacology

Published: August 31, 2015

Tri-band spectroscopic optical coherence tomography based on optical parametric amplification for lipid and vessel visualization.

Tri-band spectroscopic optical coherence tomography based on optical parametric amplification for lipid and vessel visualization.

Journal: Journal of biomedical optics

Published: August 10, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026